Education
About Us
Working with TipRanks
Follow Us
Medline (MDLN)
NASDAQ:MDLN
MDLN Stock Chart & Stats
$43.59
--
Market closed
$43.59
--
Day’s Range― - ―
52-Week Range$34.89 - $50.88
Previous CloseN/A
VolumeN/A
Average Volume (3M)8.56M
Market Cap
$56.13B
Enterprise Value$45.30B
Total Cash (Recent Filing)$1.94B
Total Debt (Recent Filing)$12.56B
Price to Earnings (P/E)29.4
Beta2.98
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding811,647,500
10 Day Avg. Volume1,994,195
30 Day Avg. Volume8,556,617
Financial Highlights & Ratios
PEG Ratio-4.97
Price to Book (P/B)3.18
Price to Sales (P/S)1.20
P/FCF Ratio19.56
Enterprise Value/Market Cap0.81
Enterprise Value/Revenue1.59
Enterprise Value/Gross Profit6.48
Enterprise Value/Ebitda14.58
Forecast
1Y Price Target
$52.29Price Target Upside19.96% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering27
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Scale & Diversified ModelMedline's integrated manufacturing plus broad distribution to hospitals, surgery centers and long-term care creates recurring volume and buying leverage. Durable scale supports procurement advantages, contract retention and reinvestment capacity across market cycles.
Improving Gross MarginsSustained gross margin expansion suggests lasting benefits from product mix (higher-margin consumables), pricing and cost control. Higher gross margins provide structural cushion to absorb SG&A or input-cost swings and support longer-term profitability.
Stronger Cash GenerationStable operating cash flow and notable free cash flow improvement in 2025 strengthen the firm's ability to fund capex, repay debt, and support working-capital needs. Reliable cash generation underpins strategic flexibility and deleveraging over the medium term.
Bears Say
Meaningful LeverageDebt-to-equity near or above 1x limits financial flexibility if volumes slow or margins compress. Higher leverage increases interest and refinancing risk, reduces room for opportunistic investment, and amplifies downside in cyclical stress over the next several quarters.
Earnings-to-cash InconsistencyPersistent gap between reported earnings and cash flow implies working-capital or timing effects, weakening earnings quality. If growth requires more inventory or receivables, cash strain could intensify and hinder sustainable cash available for debt paydown or investments.
Margin Volatility / Limited Net Profit ConversionWhile gross margins improved, net margin compression shows scale hasn't fully converted to bottom-line gains. Structural cost pressures, SG&A or mix shifts could persist, leaving profitability vulnerable and limiting durable earnings leverage from revenue growth.
Medline News
MDLN FAQ
What was Medline’s price range in the past 12 months?
Medline lowest stock price was $34.89 and its highest was $50.88 in the past 12 months.
What is Medline’s market cap?
Medline’s market cap is $56.13B.
When is Medline’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Medline’s earnings last quarter?
Currently, no data Available
Is Medline overvalued?
According to Wall Street analysts Medline’s price is currently Undervalued.
Does Medline pay dividends?
Medline does not currently pay dividends.
What is Medline’s EPS estimate?
Medline’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medline have?
Medline has 811,647,500 shares outstanding.
What happened to Medline’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Medline?
Currently, no hedge funds are holding shares in MDLN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Medline Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$52.29 (19.96% Upside)
$52.29 (19.96% Upside)
Blogger Sentiment
Bullish
MDLN Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $9.6B over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.3%
Last 30 Days ▼ 0.5%
Last 30 Days ▼ 0.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Fundamentals
Return on Equity
7.59%
Trailing 12-Months
Asset Growth
6.97%
Trailing 12-Months
Company Description
Medline
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services such as, consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. Medline Inc. was founded in 1966 and is based in Northfield, Illinois.
MDLN Earnings Call
Q4 2026
0:00 / 0:00
MDLN Stock 12 Month Forecast
Average Price Target
$52.29
▲(19.96% Upside)
Baxter International
―
Becton Dickinson
―
ICU Medical
―
Merit Medical Systems
―
Teleflex
―